Global Biological Sample Cryopreservation Market Outlook and Growth Opportunities 2026

Biological Sample Cryopreservation encompasses the controlled freezing, vitrification, and cryogenic storage technologies used to preserve living cells, tissues, reproductive materials, microorganisms, and temperature sensitive biological specimens for subsequent recovery, analysis, or biological use. The underlying preservation mechanism involves reducing molecular mobility, enzymatic activity, and biochemical degradation at ultralow temperatures while limiting structural and functional damage associated with ice crystallization, osmotic imbalance, solute concentration, and membrane disruption. Conventional slow freezing applies controlled cooling rates to promote extracellular ice formation and cellular dehydration while reducing intracellular ice formation. Vitrification uses higher cryoprotectant concentrations and rapid temperature transitions to produce an amorphous solid state with minimal ice crystallization. Cryoprotective formulations incorporate permeating agents such as dimethyl sulfoxide, glycerol, and ethylene glycol, together with nonpermeating sugars, buffering systems, and other formulation components selected according to sample characteristics and freezing methods. Preservation performance depends on the interaction between cooling rate, cryoprotectant composition, sample volume, thermal history, storage temperature, and subsequent warming conditions.
Commercial cryopreservation technologies include programmable controlled rate freezers, mechanical ultralow temperature and cryogenic freezers, liquid nitrogen storage systems, automated cryogenic sample repositories, and specialized cryopreservation media. Equipment configurations incorporate cascade refrigeration circuits, liquid nitrogen cooling and distribution assemblies, vacuum insulated stainless steel vessels, thermal control systems, and automated sample handling mechanisms. Mechanical freezers operating near minus 80°C accommodate biological materials with compatible storage requirements, while systems operating near minus 150°C and liquid nitrogen environments approaching minus 196°C are used for extended preservation of viable cellular specimens. Cryogenic storage may employ liquid phase or nitrogen vapor phase configurations, with storage architecture determined by sample characteristics, thermal stability requirements, and contamination considerations. Commercial applications encompass biological sample repositories, biomedical research, biopharmaceutical cell banking and manufacturing, cell and gene therapy, assisted reproduction, clinical specimen preservation, and animal breeding. The product market covers dedicated freezing and cryogenic storage equipment and formulated cryopreservation media used directly in biological preservation. Independent storage and logistics services, general laboratory refrigeration, standalone sample packaging consumables, and unrelated laboratory equipment fall outside the product revenue boundary.
Product & engineering
Understand the product.
Biological Sample Cryopreservation encompasses the controlled freezing, vitrification, and cryogenic storage technologies used to preserve living cells, tissues, reproductive materials, microorganisms, and temperature sensitive biological specimens for subsequent recovery, analysis, or biological use. The underlying preservation mechanism involves reducing molecular mobility, enzymatic activity, and biochemical degradation at ultralow temperatures while limiting structural and functional damage associated with ice crystallization, osmotic imbalance, solute concentration, and membrane disruption. Conventional slow freezing applies controlled cooling rates to promote extracellular ice formation and cellular dehydration while reducing intracellular ice formation. Vitrification uses higher cryoprotectant concentrations and rapid temperature transitions to produce an amorphous solid state with minimal ice crystallization. Cryoprotective formulations incorporate permeating agents such as dimethyl sulfoxide, glycerol, and ethylene glycol, together with nonpermeating sugars, buffering systems, and other formulation components selected according to sample characteristics and freezing methods. Preservation performance depends on the interaction between cooling rate, cryoprotectant composition, sample volume, thermal history, storage temperature, and subsequent warming conditions.
Commercial cryopreservation technologies include programmable controlled rate freezers, mechanical ultralow temperature and cryogenic freezers, liquid nitrogen storage systems, automated cryogenic sample repositories, and specialized cryopreservation media. Equipment configurations incorporate cascade refrigeration circuits, liquid nitrogen cooling and distribution assemblies, vacuum insulated stainless steel vessels, thermal control systems, and automated sample handling mechanisms. Mechanical freezers operating near minus 80°C accommodate biological materials with compatible storage requirements, while systems operating near minus 150°C and liquid nitrogen environments approaching minus 196°C are used for extended preservation of viable cellular specimens. Cryogenic storage may employ liquid phase or nitrogen vapor phase configurations, with storage architecture determined by sample characteristics, thermal stability requirements, and contamination considerations. Commercial applications encompass biological sample repositories, biomedical research, biopharmaceutical cell banking and manufacturing, cell and gene therapy, assisted reproduction, clinical specimen preservation, and animal breeding. The product market covers dedicated freezing and cryogenic storage equipment and formulated cryopreservation media used directly in biological preservation. Independent storage and logistics services, general laboratory refrigeration, standalone sample packaging consumables, and unrelated laboratory equipment fall outside the product revenue boundary.
Selected research
Market Outlook & Growth Opportunities
Global Biological Sample Cryopreservation Market Outlook and Growth Opportunities 2026
MARKET AT A GLANCE
Scale & outlook
- 2024
- ≈ 860USD million
- 2032
- 3,057.45USD million
Select a bar to inspect its value.
Source: APO Research, Inc.
Market perspective
According to APO Research, Inc, the global Biological Sample Cryopreservation market was valued at approximately USD 1,812.4 million in 2025 and is projected to reach USD 1,933.15 million in 2026 and USD 3,057.45 million by 2032, representing a compound annual growth rate (CAGR) of 7.94% from 2026 to 2032. Market revenue comprises dedicated controlled rate freezing equipment, ultralow temperature and cryogenic storage systems, automated biological sample repositories, and commercial cryopreservation media. Growth is driven by expanding biological specimen inventories, increased production of cell based therapeutics, and replacement of aging laboratory storage equipment. Equipment revenue depends on new installations, replacement cycles, and average selling prices, while cryopreservation media consumption follows the number of biological samples and cell manufacturing batches processed. Automated liquid nitrogen storage systems increase equipment expenditure per installation where sample capacity, retrieval frequency, and handling requirements justify additional capital investment.
Ultralow temperature freezers represent an established component of biological sample storage infrastructure. PHC Group estimated the global ultralow temperature freezer market at approximately USD 860 million in 2024 and identified emerging replacement demand for energy efficient equipment among pharmaceutical manufacturers and contract development and manufacturing organizations. Research institutions and biobanks face similar requirements as existing freezer fleets age and electricity consumption becomes a larger component of operating expenditure. In China, Haier Biomedical manufactures ultralow temperature storage equipment in Qingdao and intelligent liquid nitrogen storage systems in Chengdu, providing domestic manufacturing capacity across conventional and cryogenic storage technologies. Equipment demand in China and other Asian markets is influenced by biological sample repository development, pharmaceutical manufacturing investment, and the adoption of automated storage systems. North America, Europe, and Japan additionally generate replacement demand from established laboratory and biopharmaceutical infrastructure. Conventional freezer pricing remains subject to manufacturer competition, while automated cryogenic installations carry higher equipment values associated with insulated storage vessels, robotic handling, monitoring, and temperature management systems.
Cryogenic storage equipment and specialized preservation media are also influenced by the commercialization of advanced therapies and reproductive technologies. Cryoport reported USD 79.68 million in Life Sciences Products revenue in 2025, an increase of 6.6%, with stronger product demand in Europe, the Middle East, Africa, and Asia Pacific, alongside animal health applications in the Americas. Its product revenue includes cryogenic storage and transport equipment, reflecting demand from biological repositories, reproductive material preservation, and commercial cell therapy supply chains. BioLife Solutions reported USD 96.2 million in 2025 revenue, with biopreservation media accounting for approximately 87% of its business, including cryogenic freezing and hypothermic preservation formulations. Repligen completed its acquisition of BioLife Solutions in October 2026, adding the CryoStor cryopreservation media family to its bioprocessing business. As cell therapies advance from clinical development into commercial manufacturing, repeated production batches and frozen cellular inventories increase consumption of qualified freezing formulations. Cryoprotectant composition, post thaw cell recovery, and manufacturing process compatibility influence product selection and limit rapid substitution of established formulations. The market outlook consequently reflects continued equipment installations and replacements, a rising contribution from automated cryogenic storage, and recurring preservation media purchases tied to biological manufacturing activity.
Full market overview
This report provides an overview of the global Biological Sample Cryopreservation market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Biological Sample Cryopreservation and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Biological Sample Cryopreservation revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Biological Sample Cryopreservation market.
Biological Sample Cryopreservation Segment by Company
- Thermo Fisher Scientific
- Haier Biomedical
- PHCbi
- Repligen
- Cryoport
- Azenta Life Sciences
- Cytiva
- Sartorius
- FUJIFILM Biosciences
- Lonza
- Corning
- Eppendorf
- Greiner
- SARSTEDT
- Terumo
- CooperSurgical
- Vitrolife
- Nexpring Health
- Macopharma
- Miltenyi Biotec
- STEMCELL Technologies
- Kitazato
- Zhongke Meiling Cryogenics
- AUCMA
- BIOBASE
- Genepoint Technologies
- Origincell Biological Cryo Equipment
- Basecare Medical
- Hamilton Company
- LiCONiC
- ASKION
- SPT Labtech
- B Medical Systems
- Custom Biogenic Systems
- IC Biomedical
- Cryo Bio System
- Stirling Ultracold
- Helmer Scientific
- Micronic
- OriGen Biomedical
- BINDER
- Liebherr
- Esco Lifesciences
- Cryopal
- Cryotherm
- Cryo Diffusion
- Statebourne Cryogenics
- Celltrio
- ThermoGenesis
- Jiangsu SERLNG
- SYLAB
- Consarctic
- PromoCell
- FertiPro
- CryoLogic
- Cryofab
Biological Sample Cryopreservation Segment by Type
- Cryopreservation Equipment
- Cryopreservation Media & Reagents
- Cryopreservation Containers & Accessories
- Cryopreservation Services
Biological Sample Cryopreservation Segment by Application
- Biobanking
- Biomedical Research
- Biopharmaceutical Manufacturing
- Cell & Gene Therapy
- Assisted Reproduction
- Clinical Diagnostics
- Animal Breeding
Biological Sample Cryopreservation Segment by Region
- North America
- United States
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Spain
- Netherlands
- Switzerland
- Sweden
- Poland
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Australia
- Taiwan
- Southeast Asia
- South America
- Brazil
- Argentina
- Chile
- Colombia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Türkiye
- GCC Countries
Study Objectives
- To analyze and research the global Biological Sample Cryopreservation status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.
- To present the Biological Sample Cryopreservation key companies, revenue, market share, and recent developments.
- To split the Biological Sample Cryopreservation breakdown data by regions, type, companies, and application.
- To analyze the global and key regions Biological Sample Cryopreservation market potential and advantage, opportunity and challenge, restraints, and risks.
- To identify Biological Sample Cryopreservation significant trends, drivers, influence factors in global and regions.
- To analyze Biological Sample Cryopreservation competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
- This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Biological Sample Cryopreservation market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
- This report will help stakeholders to understand the global industry status and trends of Biological Sample Cryopreservation and provides them with information on key market drivers, restraints, challenges, and opportunities.
- This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
- This report stays updated with novel technology integration, features, and the latest developments in the market.
- This report helps stakeholders to gain insights into which regions to target globally.
- This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Biological Sample Cryopreservation.
- This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
- Chapter 1: Introduces the report scope of the report, global total market size.
- Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Biological Sample Cryopreservation industry.
- Chapter 3: Detailed analysis of Biological Sample Cryopreservation company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
- Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
- Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
- Chapter 6: Sales value of Biological Sample Cryopreservation in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.
- Chapter 7: Sales value of Biological Sample Cryopreservation in country level. It provides sigmate data by Type, and by Application for each country/region.
- Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
- Chapter 9: Concluding Insights.
More report detail
Tables and figures
List of Tables
- Table 1. Biological Sample Cryopreservation Industry Trends
- Table 2. Biological Sample Cryopreservation Industry Drivers
- Table 3. Biological Sample Cryopreservation Industry Opportunities and Challenges
- Table 4. Biological Sample Cryopreservation Industry Restraints
- Table 5. Global Biological Sample Cryopreservation Revenue by Company (US$ Million) & (2021-2026)
- Table 6. Global Biological Sample Cryopreservation Revenue Share by Company (2021-2026)
- Table 7. Global Biological Sample Cryopreservation Company Ranking, (2024-2026) & (US$ Million)
- Table 8. Global Biological Sample Cryopreservation Key Company Manufacturing Base & Headquarters
- Table 9. Global Biological Sample Cryopreservation Company, Product Type & Application
- Table 10. Global Biological Sample Cryopreservation Company Establishment Date
- Table 11. Global Company Market Concentration Ratio (CR5 and HHI)
- Table 12. Global Biological Sample Cryopreservation by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025)
- Table 13. Mergers & Acquisitions, Expansion
- Table 14. Significant Companies of Cryopreservation Equipment
- Table 15. Significant Companies of Cryopreservation Media & Reagents
- Table 16. Significant Companies of Cryopreservation Containers & Accessories
- Table 17. Significant Companies of Cryopreservation Services
- Table 18. Global Biological Sample Cryopreservation Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million)
- Table 19. Global Biological Sample Cryopreservation Sales Value by Type (2021-2026) & (US$ Million)
- Table 20. Global Biological Sample Cryopreservation Sales Value by Type (2027-2032) & (US$ Million)
- Table 21. Global Biological Sample Cryopreservation Sales Value Share by Type (2021-2026)
- Table 22. Global Biological Sample Cryopreservation Sales Value Share by Type (2027-2032)
- Table 23. Significant Companies of Biobanking
- Table 24. Significant Companies of Biomedical Research
- Table 25. Significant Companies of Biopharmaceutical Manufacturing
- Table 26. Significant Companies of Cell & Gene Therapy
- Table 27. Significant Companies of Assisted Reproduction
- Table 28. Significant Companies of Clinical Diagnostics
- Table 29. Significant Companies of Animal Breeding
- Table 30. Global Biological Sample Cryopreservation Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million)
- Table 31. Global Biological Sample Cryopreservation Sales Value by Application (2021-2026) & (US$ Million)
- Table 32. Global Biological Sample Cryopreservation Sales Value by Application (2027-2032) & (US$ Million)
- Table 33. Global Biological Sample Cryopreservation Sales Value Share by Application (2021-2026)
- Table 34. Global Biological Sample Cryopreservation Sales Value Share by Application (2027-2032)
- Table 35. Global Biological Sample Cryopreservation Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million)
- Table 36. Global Biological Sample Cryopreservation Sales Value by Region (2021-2026) & (US$ Million)
- Table 37. Global Biological Sample Cryopreservation Sales Value Share by Region (2021-2026)
- Table 38. Global Biological Sample Cryopreservation Sales Value by Region (2027-2032) & (US$ Million)
- Table 39. Global Biological Sample Cryopreservation Sales Value Share by Region (2027-2032)
- Table 40. Global Biological Sample Cryopreservation Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million)
- Table 41. Global Biological Sample Cryopreservation Sales Value by Country (2021-2026) & (US$ Million)
- Table 42. Global Biological Sample Cryopreservation Sales Value Market Share by Country (2021-2026)
- Table 43. Global Biological Sample Cryopreservation Sales Value by Country (2027-2032) & (US$ Million)
- Table 44. Global Biological Sample Cryopreservation Sales Value Market Share by Country (2027-2032)
- Table 45. Thermo Fisher Scientific Company Information
- Table 46. Thermo Fisher Scientific Business Overview
- Table 47. Thermo Fisher Scientific Biological Sample Cryopreservation Revenue (US$ Million) and Gross Margin (2021-2026)
- Table 48. Thermo Fisher Scientific Biological Sample Cryopreservation Product Portfolio
- Table 49. Thermo Fisher Scientific Recent Development
- Table 50. Haier Biomedical Company Information
- Table 51. Haier Biomedical Business Overview
- Table 52. Haier Biomedical Biological Sample Cryopreservation Revenue (US$ Million) and Gross Margin (2021-2026)
- Table 53. Haier Biomedical Biological Sample Cryopreservation Product Portfolio
- Table 54. Haier Biomedical Recent Development
- Table 55. PHCbi Company Information
- Table 56. PHCbi Business Overview
- Table 57. PHCbi Biological Sample Cryopreservation Revenue (US$ Million) and Gross Margin (2021-2026)
- Table 58. PHCbi Biological Sample Cryopreservation Product Portfolio
- Table 59. PHCbi Recent Development
- Table 60. Repligen Company Information
- Table 61. Repligen Business Overview
- Table 62. Repligen Biological Sample Cryopreservation Revenue (US$ Million) and Gross Margin (2021-2026)
- Table 63. Repligen Biological Sample Cryopreservation Product Portfolio
- Table 64. Repligen Recent Development
- Table 65. Cryoport Company Information
- Table 66. Cryoport Business Overview
- Table 67. Cryoport Biological Sample Cryopreservation Revenue (US$ Million) and Gross Margin (2021-2026)
- Table 68. Cryoport Biological Sample Cryopreservation Product Portfolio
- Table 69. Cryoport Recent Development
- Table 70. Azenta Life Sciences Company Information
- Table 71. Azenta Life Sciences Business Overview
- Table 72. Azenta Life Sciences Biological Sample Cryopreservation Revenue (US$ Million) and Gross Margin (2021-2026)
- Table 73. Azenta Life Sciences Biological Sample Cryopreservation Product Portfolio
- Table 74. Azenta Life Sciences Recent Development
- Table 75. Cytiva Company Information
- Table 76. Cytiva Business Overview
- Table 77. Cytiva Biological Sample Cryopreservation Revenue (US$ Million) and Gross Margin (2021-2026)
- Table 78. Cytiva Biological Sample Cryopreservation Product Portfolio
- Table 79. Cytiva Recent Development
- Table 80. Sartorius Company Information
- Table 81. Sartorius Business Overview
- Table 82. Sartorius Biological Sample Cryopreservation Revenue (US$ Million) and Gross Margin (2021-2026)
- Table 83. Sartorius Biological Sample Cryopreservation Product Portfolio
- Table 84. Sartorius Recent Development
- Table 85. FUJIFILM Biosciences Company Information
- Table 86. FUJIFILM Biosciences Business Overview
- Table 87. FUJIFILM Biosciences Biological Sample Cryopreservation Revenue (US$ Million) and Gross Margin (2021-2026)
- Table 88. FUJIFILM Biosciences Biological Sample Cryopreservation Product Portfolio
- Table 89. FUJIFILM Biosciences Recent Development
- Table 90. Lonza Company Information
- Table 91. Lonza Business Overview
- Table 92. Lonza Biological Sample Cryopreservation Revenue (US$ Million) and Gross Margin (2021-2026)
- Table 93. Lonza Biological Sample Cryopreservation Product Portfolio
- Table 94. Lonza Recent Development
- Table 95. Corning Company Information
- Table 96. Corning Business Overview
- Table 97. Corning Biological Sample Cryopreservation Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
- Table 98. Corning Biological Sample Cryopreservation Product Portfolio
- Table 99. Corning Recent Development
- Table 100. Eppendorf Company Information
- Table 101. Eppendorf Business Overview
- Table 102. Eppendorf Biological Sample Cryopreservation Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
- Table 103. Eppendorf Biological Sample Cryopreservation Product Portfolio
- Table 104. Eppendorf Recent Development
- Table 105. Greiner Company Information
- Table 106. Greiner Business Overview
- Table 107. Greiner Biological Sample Cryopreservation Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
- Table 108. Greiner Biological Sample Cryopreservation Product Portfolio
- Table 109. Greiner Recent Development
- Table 110. SARSTEDT Company Information
- Table 111. SARSTEDT Business Overview
- Table 112. SARSTEDT Biological Sample Cryopreservation Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
- Table 113. SARSTEDT Biological Sample Cryopreservation Product Portfolio
- Table 114. SARSTEDT Recent Development
- Table 115. Terumo Company Information
- Table 116. Terumo Business Overview
- Table 117. Terumo Biological Sample Cryopreservation Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
- Table 118. Terumo Biological Sample Cryopreservation Product Portfolio
- Table 119. Terumo Recent Development
- Table 120. CooperSurgical Company Information
- Table 121. CooperSurgical Business Overview
- Table 122. CooperSurgical Biological Sample Cryopreservation Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
- Table 123. CooperSurgical Biological Sample Cryopreservation Product Portfolio
- Table 124. CooperSurgical Recent Development
- Table 125. Vitrolife Company Information
- Table 126. Vitrolife Business Overview
- Table 127. Vitrolife Biological Sample Cryopreservation Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
- Table 128. Vitrolife Biological Sample Cryopreservation Product Portfolio
- Table 129. Vitrolife Recent Development
- Table 130. Nexpring Health Company Information
- Table 131. Nexpring Health Business Overview
- Table 132. Nexpring Health Biological Sample Cryopreservation Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
- Table 133. Nexpring Health Biological Sample Cryopreservation Product Portfolio
- Table 134. Nexpring Health Recent Development
- Table 135. Macopharma Company Information
- Table 136. Macopharma Business Overview
- Table 137. Macopharma Biological Sample Cryopreservation Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
- Table 138. Macopharma Biological Sample Cryopreservation Product Portfolio
- Table 139. Macopharma Recent Development
- Table 140. Miltenyi Biotec Company Information
- Table 141. Miltenyi Biotec Business Overview
- Table 142. Miltenyi Biotec Biological Sample Cryopreservation Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
- Table 143. Miltenyi Biotec Biological Sample Cryopreservation Product Portfolio
- Table 144. Miltenyi Biotec Recent Development
- Table 145. STEMCELL Technologies Company Information
- Table 146. STEMCELL Technologies Business Overview
- Table 147. STEMCELL Technologies Biological Sample Cryopreservation Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
- Table 148. STEMCELL Technologies Biological Sample Cryopreservation Product Portfolio
- Table 149. STEMCELL Technologies Recent Development
- Table 150. Kitazato Company Information
- Table 151. Kitazato Business Overview
- Table 152. Kitazato Biological Sample Cryopreservation Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
- Table 153. Kitazato Biological Sample Cryopreservation Product Portfolio
- Table 154. Kitazato Recent Development
- Table 155. Zhongke Meiling Cryogenics Company Information
- Table 156. Zhongke Meiling Cryogenics Business Overview
- Table 157. Zhongke Meiling Cryogenics Biological Sample Cryopreservation Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
- Table 158. Zhongke Meiling Cryogenics Biological Sample Cryopreservation Product Portfolio
- Table 159. Zhongke Meiling Cryogenics Recent Development
- Table 160. AUCMA Company Information
- Table 161. AUCMA Business Overview
- Table 162. AUCMA Biological Sample Cryopreservation Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
- Table 163. AUCMA Biological Sample Cryopreservation Product Portfolio
- Table 164. AUCMA Recent Development
- Table 165. BIOBASE Company Information
- Table 166. BIOBASE Business Overview
- Table 167. BIOBASE Biological Sample Cryopreservation Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
- Table 168. BIOBASE Biological Sample Cryopreservation Product Portfolio
- Table 169. BIOBASE Recent Development
- Table 170. Genepoint Technologies Company Information
- Table 171. Genepoint Technologies Business Overview
- Table 172. Genepoint Technologies Biological Sample Cryopreservation Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
- Table 173. Genepoint Technologies Biological Sample Cryopreservation Product Portfolio
- Table 174. Genepoint Technologies Recent Development
- Table 175. Origincell Biological Cryo Equipment Company Information
- Table 176. Origincell Biological Cryo Equipment Business Overview
- Table 177. Origincell Biological Cryo Equipment Biological Sample Cryopreservation Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
- Table 178. Origincell Biological Cryo Equipment Biological Sample Cryopreservation Product Portfolio
- Table 179. Origincell Biological Cryo Equipment Recent Development
- Table 180. Basecare Medical Company Information
- Table 181. Basecare Medical Business Overview
- Table 182. Basecare Medical Biological Sample Cryopreservation Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
- Table 183. Basecare Medical Biological Sample Cryopreservation Product Portfolio
- Table 184. Basecare Medical Recent Development
- Table 185. Hamilton Company Company Information
- Table 186. Hamilton Company Business Overview
- Table 187. Hamilton Company Biological Sample Cryopreservation Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
- Table 188. Hamilton Company Biological Sample Cryopreservation Product Portfolio
- Table 189. Hamilton Company Recent Development
- Table 190. LiCONiC Company Information
- Table 191. LiCONiC Business Overview
- Table 192. LiCONiC Biological Sample Cryopreservation Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
- Table 193. LiCONiC Biological Sample Cryopreservation Product Portfolio
- Table 194. LiCONiC Recent Development
- Table 195. ASKION Company Information
- Table 196. ASKION Business Overview
- Table 197. ASKION Biological Sample Cryopreservation Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
- Table 198. ASKION Biological Sample Cryopreservation Product Portfolio
- Table 199. ASKION Recent Development
- Table 200. SPT Labtech Company Information
- Table 201. SPT Labtech Business Overview
- Table 202. SPT Labtech Biological Sample Cryopreservation Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
- Table 203. SPT Labtech Biological Sample Cryopreservation Product Portfolio
- Table 204. SPT Labtech Recent Development
- Table 205. B Medical Systems Company Information
- Table 206. B Medical Systems Business Overview
- Table 207. B Medical Systems Biological Sample Cryopreservation Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
- Table 208. B Medical Systems Biological Sample Cryopreservation Product Portfolio
- Table 209. B Medical Systems Recent Development
- Table 210. Custom Biogenic Systems Company Information
- Table 211. Custom Biogenic Systems Business Overview
- Table 212. Custom Biogenic Systems Biological Sample Cryopreservation Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
- Table 213. Custom Biogenic Systems Biological Sample Cryopreservation Product Portfolio
- Table 214. Custom Biogenic Systems Recent Development
- Table 215. IC Biomedical Company Information
- Table 216. IC Biomedical Business Overview
- Table 217. IC Biomedical Biological Sample Cryopreservation Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
- Table 218. IC Biomedical Biological Sample Cryopreservation Product Portfolio
- Table 219. IC Biomedical Recent Development
- Table 220. Cryo Bio System Company Information
- Table 221. Cryo Bio System Business Overview
- Table 222. Cryo Bio System Biological Sample Cryopreservation Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
- Table 223. Cryo Bio System Biological Sample Cryopreservation Product Portfolio
- Table 224. Cryo Bio System Recent Development
- Table 225. Stirling Ultracold Company Information
- Table 226. Stirling Ultracold Business Overview
- Table 227. Stirling Ultracold Biological Sample Cryopreservation Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
- Table 228. Stirling Ultracold Biological Sample Cryopreservation Product Portfolio
- Table 229. Stirling Ultracold Recent Development
- Table 230. Helmer Scientific Company Information
- Table 231. Helmer Scientific Business Overview
- Table 232. Helmer Scientific Biological Sample Cryopreservation Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
- Table 233. Helmer Scientific Biological Sample Cryopreservation Product Portfolio
- Table 234. Helmer Scientific Recent Development
- Table 235. Micronic Company Information
- Table 236. Micronic Business Overview
- Table 237. Micronic Biological Sample Cryopreservation Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
- Table 238. Micronic Biological Sample Cryopreservation Product Portfolio
- Table 239. Micronic Recent Development
- Table 240. OriGen Biomedical Company Information
- Table 241. OriGen Biomedical Business Overview
- Table 242. OriGen Biomedical Biological Sample Cryopreservation Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
- Table 243. OriGen Biomedical Biological Sample Cryopreservation Product Portfolio
- Table 244. OriGen Biomedical Recent Development
- Table 245. BINDER Company Information
- Table 246. BINDER Business Overview
- Table 247. BINDER Biological Sample Cryopreservation Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
- Table 248. BINDER Biological Sample Cryopreservation Product Portfolio
- Table 249. BINDER Recent Development
- Table 250. Liebherr Company Information
- Table 251. Liebherr Business Overview
- Table 252. Liebherr Biological Sample Cryopreservation Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
- Table 253. Liebherr Biological Sample Cryopreservation Product Portfolio
- Table 254. Liebherr Recent Development
- Table 255. Esco Lifesciences Company Information
- Table 256. Esco Lifesciences Business Overview
- Table 257. Esco Lifesciences Biological Sample Cryopreservation Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
- Table 258. Esco Lifesciences Biological Sample Cryopreservation Product Portfolio
- Table 259. Esco Lifesciences Recent Development
- Table 260. Cryopal Company Information
- Table 261. Cryopal Business Overview
- Table 262. Cryopal Biological Sample Cryopreservation Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
- Table 263. Cryopal Biological Sample Cryopreservation Product Portfolio
- Table 264. Cryopal Recent Development
- Table 265. Cryotherm Company Information
- Table 266. Cryotherm Business Overview
- Table 267. Cryotherm Biological Sample Cryopreservation Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
- Table 268. Cryotherm Biological Sample Cryopreservation Product Portfolio
- Table 269. Cryotherm Recent Development
- Table 270. Cryo Diffusion Company Information
- Table 271. Cryo Diffusion Business Overview
- Table 272. Cryo Diffusion Biological Sample Cryopreservation Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
- Table 273. Cryo Diffusion Biological Sample Cryopreservation Product Portfolio
- Table 274. Cryo Diffusion Recent Development
- Table 275. Statebourne Cryogenics Company Information
- Table 276. Statebourne Cryogenics Business Overview
- Table 277. Statebourne Cryogenics Biological Sample Cryopreservation Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
- Table 278. Statebourne Cryogenics Biological Sample Cryopreservation Product Portfolio
- Table 279. Statebourne Cryogenics Recent Development
- Table 280. Celltrio Company Information
- Table 281. Celltrio Business Overview
- Table 282. Celltrio Biological Sample Cryopreservation Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
- Table 283. Celltrio Biological Sample Cryopreservation Product Portfolio
- Table 284. Celltrio Recent Development
- Table 285. ThermoGenesis Company Information
- Table 286. ThermoGenesis Business Overview
- Table 287. ThermoGenesis Biological Sample Cryopreservation Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
- Table 288. ThermoGenesis Biological Sample Cryopreservation Product Portfolio
- Table 289. ThermoGenesis Recent Development
- Table 290. Jiangsu SERLNG Company Information
- Table 291. Jiangsu SERLNG Business Overview
- Table 292. Jiangsu SERLNG Biological Sample Cryopreservation Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
- Table 293. Jiangsu SERLNG Biological Sample Cryopreservation Product Portfolio
- Table 294. Jiangsu SERLNG Recent Development
- Table 295. SYLAB Company Information
- Table 296. SYLAB Business Overview
- Table 297. SYLAB Biological Sample Cryopreservation Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
- Table 298. SYLAB Biological Sample Cryopreservation Product Portfolio
- Table 299. SYLAB Recent Development
- Table 300. Consarctic Company Information
- Table 301. Consarctic Business Overview
- Table 302. Consarctic Biological Sample Cryopreservation Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
- Table 303. Consarctic Biological Sample Cryopreservation Product Portfolio
- Table 304. Consarctic Recent Development
- Table 305. PromoCell Company Information
- Table 306. PromoCell Business Overview
- Table 307. PromoCell Biological Sample Cryopreservation Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
- Table 308. PromoCell Biological Sample Cryopreservation Product Portfolio
- Table 309. PromoCell Recent Development
- Table 310. FertiPro Company Information
- Table 311. FertiPro Business Overview
- Table 312. FertiPro Biological Sample Cryopreservation Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
- Table 313. FertiPro Biological Sample Cryopreservation Product Portfolio
- Table 314. FertiPro Recent Development
- Table 315. CryoLogic Company Information
- Table 316. CryoLogic Business Overview
- Table 317. CryoLogic Biological Sample Cryopreservation Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
- Table 318. CryoLogic Biological Sample Cryopreservation Product Portfolio
- Table 319. CryoLogic Recent Development
- Table 320. Cryofab Company Information
- Table 321. Cryofab Business Overview
- Table 322. Cryofab Biological Sample Cryopreservation Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
- Table 323. Cryofab Biological Sample Cryopreservation Product Portfolio
- Table 324. Cryofab Recent Development
- Table 325. Research Programs/Design for This Report
- Table 326. Authors List of This Report
- Table 327. Secondary Sources
- Table 328. Primary Sources
List of Figures
- Figure 1. Biological Sample Cryopreservation Product Image
- Figure 2. Global Biological Sample Cryopreservation Market Size (US$ Million), 2021 VS 2025 VS 2032
- Figure 3. Global Biological Sample Cryopreservation Market Size (2021-2032) & (US$ Million)
- Figure 4. Global Biological Sample Cryopreservation Company Revenue Ranking in 2025 (US$ Million)
- Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million)
- Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025
- Figure 7. Cryopreservation Equipment Image
- Figure 8. Cryopreservation Media & Reagents Image
- Figure 9. Cryopreservation Containers & Accessories Image
- Figure 10. Cryopreservation Services Image
- Figure 11. Global Biological Sample Cryopreservation Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million)
- Figure 12. Global Biological Sample Cryopreservation Sales Value Share 2021 VS 2025 VS 2032
- Figure 13. Global Biological Sample Cryopreservation Sales Value Share by Type (2021-2032)
- Figure 14. Biobanking Image
- Figure 15. Biomedical Research Image
- Figure 16. Biopharmaceutical Manufacturing Image
- Figure 17. Cell & Gene Therapy Image
- Figure 18. Assisted Reproduction Image
- Figure 19. Clinical Diagnostics Image
- Figure 20. Animal Breeding Image
- Figure 21. Global Biological Sample Cryopreservation Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million)
- Figure 22. Global Biological Sample Cryopreservation Sales Value Share 2021 VS 2025 VS 2032
- Figure 23. Global Biological Sample Cryopreservation Sales Value Share by Application (2021-2032)
- Figure 24. Global Biological Sample Cryopreservation Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million)
- Figure 25. Global Biological Sample Cryopreservation Sales Value Share by Region: 2021 VS 2025 VS 2032
- Figure 26. North America Biological Sample Cryopreservation Sales Value (2021-2032) & (US$ Million)
- Figure 27. North America Biological Sample Cryopreservation Sales Value Share by Country (%), 2025 VS 2032
- Figure 28. Europe Biological Sample Cryopreservation Sales Value (2021-2032) & (US$ Million)
- Figure 29. Europe Biological Sample Cryopreservation Sales Value Share by Country (%), 2025 VS 2032
- Figure 30. Asia-Pacific Biological Sample Cryopreservation Sales Value (2021-2032) & (US$ Million)
- Figure 31. Asia-Pacific Biological Sample Cryopreservation Sales Value Share by Country (%), 2025 VS 2032
- Figure 32. South America Biological Sample Cryopreservation Sales Value (2021-2032) & (US$ Million)
- Figure 33. South America Biological Sample Cryopreservation Sales Value Share by Country (%), 2025 VS 2032
- Figure 34. Middle East & Africa Biological Sample Cryopreservation Sales Value (2021-2032) & (US$ Million)
- Figure 35. Middle East & Africa Biological Sample Cryopreservation Sales Value Share by Country (%), 2025 VS 2032
- Figure 36. USA Biological Sample Cryopreservation Sales Value Growth Rate (2021-2032) & (US$ Million)
- Figure 37. USA Biological Sample Cryopreservation Sales Value Share by Type, 2025 VS 2032 & (%)
- Figure 38. USA Biological Sample Cryopreservation Sales Value Share by Application, 2025 VS 2032 & (%)
- Figure 39. Canada Biological Sample Cryopreservation Sales Value Growth Rate (2021-2032) & (US$ Million)
- Figure 40. Canada Biological Sample Cryopreservation Sales Value Share by Type, 2025 VS 2032 & (%)
- Figure 41. Canada Biological Sample Cryopreservation Sales Value Share by Application, 2025 VS 2032 & (%)
- Figure 42. Mexico Biological Sample Cryopreservation Sales Value Growth Rate (2021-2032) & (US$ Million)
- Figure 43. Mexico Biological Sample Cryopreservation Sales Value Share by Type, 2025 VS 2032 & (%)
- Figure 44. Mexico Biological Sample Cryopreservation Sales Value Share by Application, 2025 VS 2032 & (%)
- Figure 45. Germany Biological Sample Cryopreservation Sales Value Growth Rate (2021-2032) & (US$ Million)
- Figure 46. Germany Biological Sample Cryopreservation Sales Value Share by Type, 2025 VS 2032 & (%)
- Figure 47. Germany Biological Sample Cryopreservation Sales Value Share by Application, 2025 VS 2032 & (%)
- Figure 48. France Biological Sample Cryopreservation Sales Value Growth Rate (2021-2032) & (US$ Million)
- Figure 49. France Biological Sample Cryopreservation Sales Value Share by Type, 2025 VS 2032 & (%)
- Figure 50. France Biological Sample Cryopreservation Sales Value Share by Application, 2025 VS 2032 & (%)
- Figure 51. U.K. Biological Sample Cryopreservation Sales Value Growth Rate (2021-2032) & (US$ Million)
- Figure 52. U.K. Biological Sample Cryopreservation Sales Value Share by Type, 2025 VS 2032 & (%)
- Figure 53. U.K. Biological Sample Cryopreservation Sales Value Share by Application, 2025 VS 2032 & (%)
- Figure 54. Italy Biological Sample Cryopreservation Sales Value Growth Rate (2021-2032) & (US$ Million)
- Figure 55. Italy Biological Sample Cryopreservation Sales Value Share by Type, 2025 VS 2032 & (%)
- Figure 56. Italy Biological Sample Cryopreservation Sales Value Share by Application, 2025 VS 2032 & (%)
- Figure 57. Spain Biological Sample Cryopreservation Sales Value Growth Rate (2021-2032) & (US$ Million)
- Figure 58. Spain Biological Sample Cryopreservation Sales Value Share by Type, 2025 VS 2032 & (%)
- Figure 59. Spain Biological Sample Cryopreservation Sales Value Share by Application, 2025 VS 2032 & (%)
- Figure 60. Russia Biological Sample Cryopreservation Sales Value Growth Rate (2021-2032) & (US$ Million)
- Figure 61. Russia Biological Sample Cryopreservation Sales Value Share by Type, 2025 VS 2032 & (%)
- Figure 62. Russia Biological Sample Cryopreservation Sales Value Share by Application, 2025 VS 2032 & (%)
- Figure 63. Netherlands Biological Sample Cryopreservation Sales Value Growth Rate (2021-2032) & (US$ Million)
- Figure 64. Netherlands Biological Sample Cryopreservation Sales Value Share by Type, 2025 VS 2032 & (%)
- Figure 65. Netherlands Biological Sample Cryopreservation Sales Value Share by Application, 2025 VS 2032 & (%)
- Figure 66. Nordic Countries Biological Sample Cryopreservation Sales Value Growth Rate (2021-2032) & (US$ Million)
- Figure 67. Nordic Countries Biological Sample Cryopreservation Sales Value Share by Type, 2025 VS 2032 & (%)
- Figure 68. Nordic Countries Biological Sample Cryopreservation Sales Value Share by Application, 2025 VS 2032 & (%)
- Figure 69. China Biological Sample Cryopreservation Sales Value Growth Rate (2021-2032) & (US$ Million)
- Figure 70. China Biological Sample Cryopreservation Sales Value Share by Type, 2025 VS 2032 & (%)
- Figure 71. China Biological Sample Cryopreservation Sales Value Share by Application, 2025 VS 2032 & (%)
- Figure 72. Japan Biological Sample Cryopreservation Sales Value Growth Rate (2021-2032) & (US$ Million)
- Figure 73. Japan Biological Sample Cryopreservation Sales Value Share by Type, 2025 VS 2032 & (%)
- Figure 74. Japan Biological Sample Cryopreservation Sales Value Share by Application, 2025 VS 2032 & (%)
- Figure 75. South Korea Biological Sample Cryopreservation Sales Value Growth Rate (2021-2032) & (US$ Million)
- Figure 76. South Korea Biological Sample Cryopreservation Sales Value Share by Type, 2025 VS 2032 & (%)
- Figure 77. South Korea Biological Sample Cryopreservation Sales Value Share by Application, 2025 VS 2032 & (%)
- Figure 78. India Biological Sample Cryopreservation Sales Value Growth Rate (2021-2032) & (US$ Million)
- Figure 79. India Biological Sample Cryopreservation Sales Value Share by Type, 2025 VS 2032 & (%)
- Figure 80. India Biological Sample Cryopreservation Sales Value Share by Application, 2025 VS 2032 & (%)
- Figure 81. Australia Biological Sample Cryopreservation Sales Value Growth Rate (2021-2032) & (US$ Million)
- Figure 82. Australia Biological Sample Cryopreservation Sales Value Share by Type, 2025 VS 2032 & (%)
- Figure 83. Australia Biological Sample Cryopreservation Sales Value Share by Application, 2025 VS 2032 & (%)
- Figure 84. Southeast Asia Biological Sample Cryopreservation Sales Value Growth Rate (2021-2032) & (US$ Million)
- Figure 85. Southeast Asia Biological Sample Cryopreservation Sales Value Share by Type, 2025 VS 2032 & (%)
- Figure 86. Southeast Asia Biological Sample Cryopreservation Sales Value Share by Application, 2025 VS 2032 & (%)
- Figure 87. Brazil Biological Sample Cryopreservation Sales Value Growth Rate (2021-2032) & (US$ Million)
- Figure 88. Brazil Biological Sample Cryopreservation Sales Value Share by Type, 2025 VS 2032 & (%)
- Figure 89. Brazil Biological Sample Cryopreservation Sales Value Share by Application, 2025 VS 2032 & (%)
- Figure 90. Argentina Biological Sample Cryopreservation Sales Value Growth Rate (2021-2032) & (US$ Million)
- Figure 91. Argentina Biological Sample Cryopreservation Sales Value Share by Type, 2025 VS 2032 & (%)
- Figure 92. Argentina Biological Sample Cryopreservation Sales Value Share by Application, 2025 VS 2032 & (%)
- Figure 93. Chile Biological Sample Cryopreservation Sales Value Growth Rate (2021-2032) & (US$ Million)
- Figure 94. Chile Biological Sample Cryopreservation Sales Value Share by Type, 2025 VS 2032 & (%)
- Figure 95. Chile Biological Sample Cryopreservation Sales Value Share by Application, 2025 VS 2032 & (%)
- Figure 96. Colombia Biological Sample Cryopreservation Sales Value Growth Rate (2021-2032) & (US$ Million)
- Figure 97. Colombia Biological Sample Cryopreservation Sales Value Share by Type, 2025 VS 2032 & (%)
- Figure 98. Colombia Biological Sample Cryopreservation Sales Value Share by Application, 2025 VS 2032 & (%)
- Figure 99. Peru Biological Sample Cryopreservation Sales Value Growth Rate (2021-2032) & (US$ Million)
- Figure 100. Peru Biological Sample Cryopreservation Sales Value Share by Type, 2025 VS 2032 & (%)
- Figure 101. Peru Biological Sample Cryopreservation Sales Value Share by Application, 2025 VS 2032 & (%)
- Figure 102. Saudi Arabia Biological Sample Cryopreservation Sales Value Growth Rate (2021-2032) & (US$ Million)
- Figure 103. Saudi Arabia Biological Sample Cryopreservation Sales Value Share by Type, 2025 VS 2032 & (%)
- Figure 104. Saudi Arabia Biological Sample Cryopreservation Sales Value Share by Application, 2025 VS 2032 & (%)
- Figure 105. Israel Biological Sample Cryopreservation Sales Value Growth Rate (2021-2032) & (US$ Million)
- Figure 106. Israel Biological Sample Cryopreservation Sales Value Share by Type, 2025 VS 2032 & (%)
- Figure 107. Israel Biological Sample Cryopreservation Sales Value Share by Application, 2025 VS 2032 & (%)
- Figure 108. UAE Biological Sample Cryopreservation Sales Value Growth Rate (2021-2032) & (US$ Million)
- Figure 109. UAE Biological Sample Cryopreservation Sales Value Share by Type, 2025 VS 2032 & (%)
- Figure 110. UAE Biological Sample Cryopreservation Sales Value Share by Application, 2025 VS 2032 & (%)
- Figure 111. Turkey Biological Sample Cryopreservation Sales Value Growth Rate (2021-2032) & (US$ Million)
- Figure 112. Turkey Biological Sample Cryopreservation Sales Value Share by Type, 2025 VS 2032 & (%)
- Figure 113. Turkey Biological Sample Cryopreservation Sales Value Share by Application, 2025 VS 2032 & (%)
- Figure 114. Iran Biological Sample Cryopreservation Sales Value Growth Rate (2021-2032) & (US$ Million)
- Figure 115. Iran Biological Sample Cryopreservation Sales Value Share by Type, 2025 VS 2032 & (%)
- Figure 116. Iran Biological Sample Cryopreservation Sales Value Share by Application, 2025 VS 2032 & (%)
- Figure 117. Egypt Biological Sample Cryopreservation Sales Value Growth Rate (2021-2032) & (US$ Million)
- Figure 118. Egypt Biological Sample Cryopreservation Sales Value Share by Type, 2025 VS 2032 & (%)
- Figure 119. Egypt Biological Sample Cryopreservation Sales Value Share by Application, 2025 VS 2032 & (%)
- Figure 120. Years Considered
- Figure 121. Research Process
- Figure 122. Key Executives Interviewed
Scope & coverage.
By Type
- Cryopreservation Equipment
- Cryopreservation Media & Reagents
- Cryopreservation Containers & Accessories
- Cryopreservation Services
By Application
- Biobanking
- Biomedical Research
- Biopharmaceutical Manufacturing
- Cell & Gene Therapy
- Assisted Reproduction
- Clinical Diagnostics
- Animal Breeding
Companies covered
- Thermo Fisher Scientific
- Haier Biomedical
- PHCbi
- Repligen
- Cryoport
- Azenta Life Sciences
- Cytiva
- Sartorius
- FUJIFILM Biosciences
- Lonza
- Corning
- Eppendorf
- Greiner
- SARSTEDT
- Terumo
- CooperSurgical
- Vitrolife
- Nexpring Health
- Macopharma
- Miltenyi Biotec
- STEMCELL Technologies
- Kitazato
- Zhongke Meiling Cryogenics
- AUCMA
- BIOBASE
- Genepoint Technologies
- Origincell Biological Cryo Equipment
- Basecare Medical
- Hamilton Company
- LiCONiC
- ASKION
- SPT Labtech
- B Medical Systems
- Custom Biogenic Systems
- IC Biomedical
- Cryo Bio System
- Stirling Ultracold
- Helmer Scientific
- Micronic
- OriGen Biomedical
- BINDER
- Liebherr
- Esco Lifesciences
- Cryopal
- Cryotherm
- Cryo Diffusion
- Statebourne Cryogenics
- Celltrio
- ThermoGenesis
- Jiangsu SERLNG
- SYLAB
- Consarctic
- PromoCell
- FertiPro
- CryoLogic
- Cryofab
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Biological Sample Cryopreservation Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Biological Sample Cryopreservation Market Size (2021-2032)
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Biological Sample Cryopreservation Market Dynamics
- 2.1 Biological Sample Cryopreservation Industry Trends
- 2.2 Biological Sample Cryopreservation Industry Drivers
- 2.3 Biological Sample Cryopreservation Industry Opportunities and Challenges
- 2.4 Biological Sample Cryopreservation Industry Restraints
3 Biological Sample Cryopreservation Market by Company
- 3.1 Global Biological Sample Cryopreservation Company Revenue Ranking in 2025
- 3.2 Global Biological Sample Cryopreservation Revenue by Company (2021-2026)
- 3.3 Global Biological Sample Cryopreservation Company Ranking (2024-2026)
- 3.4 Global Biological Sample Cryopreservation Company Manufacturing Base and Headquarters
- 3.5 Global Biological Sample Cryopreservation Company Product Type and Application
- 3.6 Global Biological Sample Cryopreservation Company Establishment Date
- 3.7 Market Competitive Analysis
- 3.7.1 Global Biological Sample Cryopreservation Market Concentration Ratio (CR5 and HHI)
- 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
- 3.7.3 2025 Biological Sample Cryopreservation Tier 1, Tier 2, and Tier 3 Companies
- 3.8 Mergers and Acquisitions Expansion
4 Biological Sample Cryopreservation Market by Type
- 4.1 Biological Sample Cryopreservation Type Introduction
- 4.1.1 Cryopreservation Equipment
- 4.1.2 Cryopreservation Media & Reagents
- 4.1.3 Cryopreservation Containers & Accessories
- 4.1.4 Cryopreservation Services
- 4.2 Global Biological Sample Cryopreservation Sales Value by Type
- 4.2.1 Global Biological Sample Cryopreservation Sales Value by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Biological Sample Cryopreservation Sales Value by Type (2021-2032)
- 4.2.3 Global Biological Sample Cryopreservation Sales Value Share by Type (2021-2032)
5 Biological Sample Cryopreservation Market by Application
- 5.1 Biological Sample Cryopreservation Application Introduction
- 5.1.1 Biobanking
- 5.1.2 Biomedical Research
- 5.1.3 Biopharmaceutical Manufacturing
- 5.1.4 Cell & Gene Therapy
- 5.1.5 Assisted Reproduction
- 5.1.6 Clinical Diagnostics
- 5.1.7 Animal Breeding
- 5.2 Global Biological Sample Cryopreservation Sales Value by Application
- 5.2.1 Global Biological Sample Cryopreservation Sales Value by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Biological Sample Cryopreservation Sales Value by Application (2021-2032)
- 5.2.3 Global Biological Sample Cryopreservation Sales Value Share by Application (2021-2032)
6 Biological Sample Cryopreservation Regional Value Analysis
- 6.1 Global Biological Sample Cryopreservation Sales Value by Region: 2021 VS 2025 VS 2032
- 6.2 Global Biological Sample Cryopreservation Sales Value by Region (2021-2032)
- 6.2.1 Global Biological Sample Cryopreservation Sales Value by Region: 2021-2026
- 6.2.2 Global Biological Sample Cryopreservation Sales Value by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Biological Sample Cryopreservation Sales Value (2021-2032)
- 6.3.2 North America Biological Sample Cryopreservation Sales Value Share by Country, 2025 VS 2032
- 6.4 Europe
- 6.4.1 Europe Biological Sample Cryopreservation Sales Value (2021-2032)
- 6.4.2 Europe Biological Sample Cryopreservation Sales Value Share by Country, 2025 VS 2032
- 6.5 Asia-Pacific
- 6.5.1 Asia-Pacific Biological Sample Cryopreservation Sales Value (2021-2032)
- 6.5.2 Asia-Pacific Biological Sample Cryopreservation Sales Value Share by Country, 2025 VS 2032
- 6.6 South America
- 6.6.1 South America Biological Sample Cryopreservation Sales Value (2021-2032)
- 6.6.2 South America Biological Sample Cryopreservation Sales Value Share by Country, 2025 VS 2032
- 6.7 Middle East & Africa
- 6.7.1 Middle East & Africa Biological Sample Cryopreservation Sales Value (2021-2032)
- 6.7.2 Middle East & Africa Biological Sample Cryopreservation Sales Value Share by Country, 2025 VS 2032
7 Biological Sample Cryopreservation Country-level Value Analysis
- 7.1 Global Biological Sample Cryopreservation Sales Value by Country: 2021 VS 2025 VS 2032
- 7.2 Global Biological Sample Cryopreservation Sales Value by Country (2021-2032)
- 7.2.1 Global Biological Sample Cryopreservation Sales Value by Country (2021-2026)
- 7.2.2 Global Biological Sample Cryopreservation Sales Value by Country (2027-2032)
- 7.3 USA
- 7.3.1 USA Biological Sample Cryopreservation Sales Value Growth Rate (2021-2032)
- 7.3.2 USA Biological Sample Cryopreservation Sales Value Share by Type, 2025 VS 2032
- 7.3.3 USA Biological Sample Cryopreservation Sales Value Share by Application, 2025 VS 2032
- 7.4 Canada
- 7.4.1 Canada Biological Sample Cryopreservation Sales Value Growth Rate (2021-2032)
- 7.4.2 Canada Biological Sample Cryopreservation Sales Value Share by Type, 2025 VS 2032
- 7.4.3 Canada Biological Sample Cryopreservation Sales Value Share by Application, 2025 VS 2032
- 7.5 Mexico
- 7.5.1 Mexico Biological Sample Cryopreservation Sales Value Growth Rate (2021-2032)
- 7.5.2 Mexico Biological Sample Cryopreservation Sales Value Share by Type, 2025 VS 2032
- 7.5.3 Mexico Biological Sample Cryopreservation Sales Value Share by Application, 2025 VS 2032
- 7.6 Germany
- 7.6.1 Germany Biological Sample Cryopreservation Sales Value Growth Rate (2021-2032)
- 7.6.2 Germany Biological Sample Cryopreservation Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Germany Biological Sample Cryopreservation Sales Value Share by Application, 2025 VS 2032
- 7.7 France
- 7.7.1 France Biological Sample Cryopreservation Sales Value Growth Rate (2021-2032)
- 7.7.2 France Biological Sample Cryopreservation Sales Value Share by Type, 2025 VS 2032
- 7.7.3 France Biological Sample Cryopreservation Sales Value Share by Application, 2025 VS 2032
- 7.8 U.K.
- 7.8.1 U.K. Biological Sample Cryopreservation Sales Value Growth Rate (2021-2032)
- 7.8.2 U.K. Biological Sample Cryopreservation Sales Value Share by Type, 2025 VS 2032
- 7.8.3 U.K. Biological Sample Cryopreservation Sales Value Share by Application, 2025 VS 2032
- 7.9 Italy
- 7.9.1 Italy Biological Sample Cryopreservation Sales Value Growth Rate (2021-2032)
- 7.9.2 Italy Biological Sample Cryopreservation Sales Value Share by Type, 2025 VS 2032
- 7.9.3 Italy Biological Sample Cryopreservation Sales Value Share by Application, 2025 VS 2032
- 7.10 Spain
- 7.10.1 Spain Biological Sample Cryopreservation Sales Value Growth Rate (2021-2032)
- 7.10.2 Spain Biological Sample Cryopreservation Sales Value Share by Type, 2025 VS 2032
- 7.10.3 Spain Biological Sample Cryopreservation Sales Value Share by Application, 2025 VS 2032
- 7.11 Russia
- 7.11.1 Russia Biological Sample Cryopreservation Sales Value Growth Rate (2021-2032)
- 7.11.2 Russia Biological Sample Cryopreservation Sales Value Share by Type, 2025 VS 2032
- 7.11.3 Russia Biological Sample Cryopreservation Sales Value Share by Application, 2025 VS 2032
- 7.12 Netherlands
- 7.12.1 Netherlands Biological Sample Cryopreservation Sales Value Growth Rate (2021-2032)
- 7.12.2 Netherlands Biological Sample Cryopreservation Sales Value Share by Type, 2025 VS 2032
- 7.12.3 Netherlands Biological Sample Cryopreservation Sales Value Share by Application, 2025 VS 2032
- 7.13 Nordic Countries
- 7.13.1 Nordic Countries Biological Sample Cryopreservation Sales Value Growth Rate (2021-2032)
- 7.13.2 Nordic Countries Biological Sample Cryopreservation Sales Value Share by Type, 2025 VS 2032
- 7.13.3 Nordic Countries Biological Sample Cryopreservation Sales Value Share by Application, 2025 VS 2032
- 7.14 China
- 7.14.1 China Biological Sample Cryopreservation Sales Value Growth Rate (2021-2032)
- 7.14.2 China Biological Sample Cryopreservation Sales Value Share by Type, 2025 VS 2032
- 7.14.3 China Biological Sample Cryopreservation Sales Value Share by Application, 2025 VS 2032
- 7.15 Japan
- 7.15.1 Japan Biological Sample Cryopreservation Sales Value Growth Rate (2021-2032)
- 7.15.2 Japan Biological Sample Cryopreservation Sales Value Share by Type, 2025 VS 2032
- 7.15.3 Japan Biological Sample Cryopreservation Sales Value Share by Application, 2025 VS 2032
- 7.16 South Korea
- 7.16.1 South Korea Biological Sample Cryopreservation Sales Value Growth Rate (2021-2032)
- 7.16.2 South Korea Biological Sample Cryopreservation Sales Value Share by Type, 2025 VS 2032
- 7.16.3 South Korea Biological Sample Cryopreservation Sales Value Share by Application, 2025 VS 2032
- 7.17 India
- 7.17.1 India Biological Sample Cryopreservation Sales Value Growth Rate (2021-2032)
- 7.17.2 India Biological Sample Cryopreservation Sales Value Share by Type, 2025 VS 2032
- 7.17.3 India Biological Sample Cryopreservation Sales Value Share by Application, 2025 VS 2032
- 7.18 Australia
- 7.18.1 Australia Biological Sample Cryopreservation Sales Value Growth Rate (2021-2032)
- 7.18.2 Australia Biological Sample Cryopreservation Sales Value Share by Type, 2025 VS 2032
- 7.18.3 Australia Biological Sample Cryopreservation Sales Value Share by Application, 2025 VS 2032
- 7.19 Southeast Asia
- 7.19.1 Southeast Asia Biological Sample Cryopreservation Sales Value Growth Rate (2021-2032)
- 7.19.2 Southeast Asia Biological Sample Cryopreservation Sales Value Share by Type, 2025 VS 2032
- 7.19.3 Southeast Asia Biological Sample Cryopreservation Sales Value Share by Application, 2025 VS 2032
- 7.20 Brazil
- 7.20.1 Brazil Biological Sample Cryopreservation Sales Value Growth Rate (2021-2032)
- 7.20.2 Brazil Biological Sample Cryopreservation Sales Value Share by Type, 2025 VS 2032
- 7.20.3 Brazil Biological Sample Cryopreservation Sales Value Share by Application, 2025 VS 2032
- 7.21 Argentina
- 7.21.1 Argentina Biological Sample Cryopreservation Sales Value Growth Rate (2021-2032)
- 7.21.2 Argentina Biological Sample Cryopreservation Sales Value Share by Type, 2025 VS 2032
- 7.21.3 Argentina Biological Sample Cryopreservation Sales Value Share by Application, 2025 VS 2032
- 7.22 Chile
- 7.22.1 Chile Biological Sample Cryopreservation Sales Value Growth Rate (2021-2032)
- 7.22.2 Chile Biological Sample Cryopreservation Sales Value Share by Type, 2025 VS 2032
- 7.22.3 Chile Biological Sample Cryopreservation Sales Value Share by Application, 2025 VS 2032
- 7.23 Colombia
- 7.23.1 Colombia Biological Sample Cryopreservation Sales Value Growth Rate (2021-2032)
- 7.23.2 Colombia Biological Sample Cryopreservation Sales Value Share by Type, 2025 VS 2032
- 7.23.3 Colombia Biological Sample Cryopreservation Sales Value Share by Application, 2025 VS 2032
- 7.24 Peru
- 7.24.1 Peru Biological Sample Cryopreservation Sales Value Growth Rate (2021-2032)
- 7.24.2 Peru Biological Sample Cryopreservation Sales Value Share by Type, 2025 VS 2032
- 7.24.3 Peru Biological Sample Cryopreservation Sales Value Share by Application, 2025 VS 2032
- 7.25 Saudi Arabia
- 7.25.1 Saudi Arabia Biological Sample Cryopreservation Sales Value Growth Rate (2021-2032)
- 7.25.2 Saudi Arabia Biological Sample Cryopreservation Sales Value Share by Type, 2025 VS 2032
- 7.25.3 Saudi Arabia Biological Sample Cryopreservation Sales Value Share by Application, 2025 VS 2032
- 7.26 Israel
- 7.26.1 Israel Biological Sample Cryopreservation Sales Value Growth Rate (2021-2032)
- 7.26.2 Israel Biological Sample Cryopreservation Sales Value Share by Type, 2025 VS 2032
- 7.26.3 Israel Biological Sample Cryopreservation Sales Value Share by Application, 2025 VS 2032
- 7.27 UAE
- 7.27.1 UAE Biological Sample Cryopreservation Sales Value Growth Rate (2021-2032)
- 7.27.2 UAE Biological Sample Cryopreservation Sales Value Share by Type, 2025 VS 2032
- 7.27.3 UAE Biological Sample Cryopreservation Sales Value Share by Application, 2025 VS 2032
- 7.28 Turkey
- 7.28.1 Turkey Biological Sample Cryopreservation Sales Value Growth Rate (2021-2032)
- 7.28.2 Turkey Biological Sample Cryopreservation Sales Value Share by Type, 2025 VS 2032
- 7.28.3 Turkey Biological Sample Cryopreservation Sales Value Share by Application, 2025 VS 2032
- 7.29 Iran
- 7.29.1 Iran Biological Sample Cryopreservation Sales Value Growth Rate (2021-2032)
- 7.29.2 Iran Biological Sample Cryopreservation Sales Value Share by Type, 2025 VS 2032
- 7.29.3 Iran Biological Sample Cryopreservation Sales Value Share by Application, 2025 VS 2032
- 7.30 Egypt
- 7.30.1 Egypt Biological Sample Cryopreservation Sales Value Growth Rate (2021-2032)
- 7.30.2 Egypt Biological Sample Cryopreservation Sales Value Share by Type, 2025 VS 2032
- 7.30.3 Egypt Biological Sample Cryopreservation Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
- 8.1 Thermo Fisher Scientific
- 8.1.1 Thermo Fisher Scientific Company Information
- 8.1.2 Thermo Fisher Scientific Business Overview
- 8.1.3 Thermo Fisher Scientific Biological Sample Cryopreservation Revenue and Gross Margin (2021-2026)
- 8.1.4 Thermo Fisher Scientific Biological Sample Cryopreservation Product Portfolio
- 8.1.5 Thermo Fisher Scientific Recent Developments
- 8.2 Haier Biomedical
- 8.2.1 Haier Biomedical Company Information
- 8.2.2 Haier Biomedical Business Overview
- 8.2.3 Haier Biomedical Biological Sample Cryopreservation Revenue and Gross Margin (2021-2026)
- 8.2.4 Haier Biomedical Biological Sample Cryopreservation Product Portfolio
- 8.2.5 Haier Biomedical Recent Developments
- 8.3 PHCbi
- 8.3.1 PHCbi Company Information
- 8.3.2 PHCbi Business Overview
- 8.3.3 PHCbi Biological Sample Cryopreservation Revenue and Gross Margin (2021-2026)
- 8.3.4 PHCbi Biological Sample Cryopreservation Product Portfolio
- 8.3.5 PHCbi Recent Developments
- 8.4 Repligen
- 8.4.1 Repligen Company Information
- 8.4.2 Repligen Business Overview
- 8.4.3 Repligen Biological Sample Cryopreservation Revenue and Gross Margin (2021-2026)
- 8.4.4 Repligen Biological Sample Cryopreservation Product Portfolio
- 8.4.5 Repligen Recent Developments
- 8.5 Cryoport
- 8.5.1 Cryoport Company Information
- 8.5.2 Cryoport Business Overview
- 8.5.3 Cryoport Biological Sample Cryopreservation Revenue and Gross Margin (2021-2026)
- 8.5.4 Cryoport Biological Sample Cryopreservation Product Portfolio
- 8.5.5 Cryoport Recent Developments
- 8.6 Azenta Life Sciences
- 8.6.1 Azenta Life Sciences Company Information
- 8.6.2 Azenta Life Sciences Business Overview
- 8.6.3 Azenta Life Sciences Biological Sample Cryopreservation Revenue and Gross Margin (2021-2026)
- 8.6.4 Azenta Life Sciences Biological Sample Cryopreservation Product Portfolio
- 8.6.5 Azenta Life Sciences Recent Developments
- 8.7 Cytiva
- 8.7.1 Cytiva Company Information
- 8.7.2 Cytiva Business Overview
- 8.7.3 Cytiva Biological Sample Cryopreservation Revenue and Gross Margin (2021-2026)
- 8.7.4 Cytiva Biological Sample Cryopreservation Product Portfolio
- 8.7.5 Cytiva Recent Developments
- 8.8 Sartorius
- 8.8.1 Sartorius Company Information
- 8.8.2 Sartorius Business Overview
- 8.8.3 Sartorius Biological Sample Cryopreservation Revenue and Gross Margin (2021-2026)
- 8.8.4 Sartorius Biological Sample Cryopreservation Product Portfolio
- 8.8.5 Sartorius Recent Developments
- 8.9 FUJIFILM Biosciences
- 8.9.1 FUJIFILM Biosciences Company Information
- 8.9.2 FUJIFILM Biosciences Business Overview
- 8.9.3 FUJIFILM Biosciences Biological Sample Cryopreservation Revenue and Gross Margin (2021-2026)
- 8.9.4 FUJIFILM Biosciences Biological Sample Cryopreservation Product Portfolio
- 8.9.5 FUJIFILM Biosciences Recent Developments
- 8.10 Lonza
- 8.10.1 Lonza Company Information
- 8.10.2 Lonza Business Overview
- 8.10.3 Lonza Biological Sample Cryopreservation Revenue and Gross Margin (2021-2026)
- 8.10.4 Lonza Biological Sample Cryopreservation Product Portfolio
- 8.10.5 Lonza Recent Developments
- 8.11 Corning
- 8.11.1 Corning Company Information
- 8.11.2 Corning Business Overview
- 8.11.3 Corning Biological Sample Cryopreservation Revenue and Gross Margin (2021-2026)
- 8.11.4 Corning Biological Sample Cryopreservation Product Portfolio
- 8.11.5 Corning Recent Developments
- 8.12 Eppendorf
- 8.12.1 Eppendorf Company Information
- 8.12.2 Eppendorf Business Overview
- 8.12.3 Eppendorf Biological Sample Cryopreservation Revenue and Gross Margin (2021-2026)
- 8.12.4 Eppendorf Biological Sample Cryopreservation Product Portfolio
- 8.12.5 Eppendorf Recent Developments
- 8.13 Greiner
- 8.13.1 Greiner Company Information
- 8.13.2 Greiner Business Overview
- 8.13.3 Greiner Biological Sample Cryopreservation Revenue and Gross Margin (2021-2026)
- 8.13.4 Greiner Biological Sample Cryopreservation Product Portfolio
- 8.13.5 Greiner Recent Developments
- 8.14 SARSTEDT
- 8.14.1 SARSTEDT Company Information
- 8.14.2 SARSTEDT Business Overview
- 8.14.3 SARSTEDT Biological Sample Cryopreservation Revenue and Gross Margin (2021-2026)
- 8.14.4 SARSTEDT Biological Sample Cryopreservation Product Portfolio
- 8.14.5 SARSTEDT Recent Developments
- 8.15 Terumo
- 8.15.1 Terumo Company Information
- 8.15.2 Terumo Business Overview
- 8.15.3 Terumo Biological Sample Cryopreservation Revenue and Gross Margin (2021-2026)
- 8.15.4 Terumo Biological Sample Cryopreservation Product Portfolio
- 8.15.5 Terumo Recent Developments
- 8.16 CooperSurgical
- 8.16.1 CooperSurgical Company Information
- 8.16.2 CooperSurgical Business Overview
- 8.16.3 CooperSurgical Biological Sample Cryopreservation Revenue and Gross Margin (2021-2026)
- 8.16.4 CooperSurgical Biological Sample Cryopreservation Product Portfolio
- 8.16.5 CooperSurgical Recent Developments
- 8.17 Vitrolife
- 8.17.1 Vitrolife Company Information
- 8.17.2 Vitrolife Business Overview
- 8.17.3 Vitrolife Biological Sample Cryopreservation Revenue and Gross Margin (2021-2026)
- 8.17.4 Vitrolife Biological Sample Cryopreservation Product Portfolio
- 8.17.5 Vitrolife Recent Developments
- 8.18 Nexpring Health
- 8.18.1 Nexpring Health Company Information
- 8.18.2 Nexpring Health Business Overview
- 8.18.3 Nexpring Health Biological Sample Cryopreservation Revenue and Gross Margin (2021-2026)
- 8.18.4 Nexpring Health Biological Sample Cryopreservation Product Portfolio
- 8.18.5 Nexpring Health Recent Developments
- 8.19 Macopharma
- 8.19.1 Macopharma Company Information
- 8.19.2 Macopharma Business Overview
- 8.19.3 Macopharma Biological Sample Cryopreservation Revenue and Gross Margin (2021-2026)
- 8.19.4 Macopharma Biological Sample Cryopreservation Product Portfolio
- 8.19.5 Macopharma Recent Developments
- 8.20 Miltenyi Biotec
- 8.20.1 Miltenyi Biotec Company Information
- 8.20.2 Miltenyi Biotec Business Overview
- 8.20.3 Miltenyi Biotec Biological Sample Cryopreservation Revenue and Gross Margin (2021-2026)
- 8.20.4 Miltenyi Biotec Biological Sample Cryopreservation Product Portfolio
- 8.20.5 Miltenyi Biotec Recent Developments
- 8.21 STEMCELL Technologies
- 8.21.1 STEMCELL Technologies Company Information
- 8.21.2 STEMCELL Technologies Business Overview
- 8.21.3 STEMCELL Technologies Biological Sample Cryopreservation Revenue and Gross Margin (2021-2026)
- 8.21.4 STEMCELL Technologies Biological Sample Cryopreservation Product Portfolio
- 8.21.5 STEMCELL Technologies Recent Developments
- 8.22 Kitazato
- 8.22.1 Kitazato Company Information
- 8.22.2 Kitazato Business Overview
- 8.22.3 Kitazato Biological Sample Cryopreservation Revenue and Gross Margin (2021-2026)
- 8.22.4 Kitazato Biological Sample Cryopreservation Product Portfolio
- 8.22.5 Kitazato Recent Developments
- 8.23 Zhongke Meiling Cryogenics
- 8.23.1 Zhongke Meiling Cryogenics Company Information
- 8.23.2 Zhongke Meiling Cryogenics Business Overview
- 8.23.3 Zhongke Meiling Cryogenics Biological Sample Cryopreservation Revenue and Gross Margin (2021-2026)
- 8.23.4 Zhongke Meiling Cryogenics Biological Sample Cryopreservation Product Portfolio
- 8.23.5 Zhongke Meiling Cryogenics Recent Developments
- 8.24 AUCMA
- 8.24.1 AUCMA Company Information
- 8.24.2 AUCMA Business Overview
- 8.24.3 AUCMA Biological Sample Cryopreservation Revenue and Gross Margin (2021-2026)
- 8.24.4 AUCMA Biological Sample Cryopreservation Product Portfolio
- 8.24.5 AUCMA Recent Developments
- 8.25 BIOBASE
- 8.25.1 BIOBASE Company Information
- 8.25.2 BIOBASE Business Overview
- 8.25.3 BIOBASE Biological Sample Cryopreservation Revenue and Gross Margin (2021-2026)
- 8.25.4 BIOBASE Biological Sample Cryopreservation Product Portfolio
- 8.25.5 BIOBASE Recent Developments
- 8.26 Genepoint Technologies
- 8.26.1 Genepoint Technologies Company Information
- 8.26.2 Genepoint Technologies Business Overview
- 8.26.3 Genepoint Technologies Biological Sample Cryopreservation Revenue and Gross Margin (2021-2026)
- 8.26.4 Genepoint Technologies Biological Sample Cryopreservation Product Portfolio
- 8.26.5 Genepoint Technologies Recent Developments
- 8.27 Origincell Biological Cryo Equipment
- 8.27.1 Origincell Biological Cryo Equipment Company Information
- 8.27.2 Origincell Biological Cryo Equipment Business Overview
- 8.27.3 Origincell Biological Cryo Equipment Biological Sample Cryopreservation Revenue and Gross Margin (2021-2026)
- 8.27.4 Origincell Biological Cryo Equipment Biological Sample Cryopreservation Product Portfolio
- 8.27.5 Origincell Biological Cryo Equipment Recent Developments
- 8.28 Basecare Medical
- 8.28.1 Basecare Medical Company Information
- 8.28.2 Basecare Medical Business Overview
- 8.28.3 Basecare Medical Biological Sample Cryopreservation Revenue and Gross Margin (2021-2026)
- 8.28.4 Basecare Medical Biological Sample Cryopreservation Product Portfolio
- 8.28.5 Basecare Medical Recent Developments
- 8.29 Hamilton Company
- 8.29.1 Hamilton Company Company Information
- 8.29.2 Hamilton Company Business Overview
- 8.29.3 Hamilton Company Biological Sample Cryopreservation Revenue and Gross Margin (2021-2026)
- 8.29.4 Hamilton Company Biological Sample Cryopreservation Product Portfolio
- 8.29.5 Hamilton Company Recent Developments
- 8.30 LiCONiC
- 8.30.1 LiCONiC Company Information
- 8.30.2 LiCONiC Business Overview
- 8.30.3 LiCONiC Biological Sample Cryopreservation Revenue and Gross Margin (2021-2026)
- 8.30.4 LiCONiC Biological Sample Cryopreservation Product Portfolio
- 8.30.5 LiCONiC Recent Developments
- 8.31 ASKION
- 8.31.1 ASKION Company Information
- 8.31.2 ASKION Business Overview
- 8.31.3 ASKION Biological Sample Cryopreservation Revenue and Gross Margin (2021-2026)
- 8.31.4 ASKION Biological Sample Cryopreservation Product Portfolio
- 8.31.5 ASKION Recent Developments
- 8.32 SPT Labtech
- 8.32.1 SPT Labtech Company Information
- 8.32.2 SPT Labtech Business Overview
- 8.32.3 SPT Labtech Biological Sample Cryopreservation Revenue and Gross Margin (2021-2026)
- 8.32.4 SPT Labtech Biological Sample Cryopreservation Product Portfolio
- 8.32.5 SPT Labtech Recent Developments
- 8.33 B Medical Systems
- 8.33.1 B Medical Systems Company Information
- 8.33.2 B Medical Systems Business Overview
- 8.33.3 B Medical Systems Biological Sample Cryopreservation Revenue and Gross Margin (2021-2026)
- 8.33.4 B Medical Systems Biological Sample Cryopreservation Product Portfolio
- 8.33.5 B Medical Systems Recent Developments
- 8.34 Custom Biogenic Systems
- 8.34.1 Custom Biogenic Systems Company Information
- 8.34.2 Custom Biogenic Systems Business Overview
- 8.34.3 Custom Biogenic Systems Biological Sample Cryopreservation Revenue and Gross Margin (2021-2026)
- 8.34.4 Custom Biogenic Systems Biological Sample Cryopreservation Product Portfolio
- 8.34.5 Custom Biogenic Systems Recent Developments
- 8.35 IC Biomedical
- 8.35.1 IC Biomedical Company Information
- 8.35.2 IC Biomedical Business Overview
- 8.35.3 IC Biomedical Biological Sample Cryopreservation Revenue and Gross Margin (2021-2026)
- 8.35.4 IC Biomedical Biological Sample Cryopreservation Product Portfolio
- 8.35.5 IC Biomedical Recent Developments
- 8.36 Cryo Bio System
- 8.36.1 Cryo Bio System Company Information
- 8.36.2 Cryo Bio System Business Overview
- 8.36.3 Cryo Bio System Biological Sample Cryopreservation Revenue and Gross Margin (2021-2026)
- 8.36.4 Cryo Bio System Biological Sample Cryopreservation Product Portfolio
- 8.36.5 Cryo Bio System Recent Developments
- 8.37 Stirling Ultracold
- 8.37.1 Stirling Ultracold Company Information
- 8.37.2 Stirling Ultracold Business Overview
- 8.37.3 Stirling Ultracold Biological Sample Cryopreservation Revenue and Gross Margin (2021-2026)
- 8.37.4 Stirling Ultracold Biological Sample Cryopreservation Product Portfolio
- 8.37.5 Stirling Ultracold Recent Developments
- 8.38 Helmer Scientific
- 8.38.1 Helmer Scientific Company Information
- 8.38.2 Helmer Scientific Business Overview
- 8.38.3 Helmer Scientific Biological Sample Cryopreservation Revenue and Gross Margin (2021-2026)
- 8.38.4 Helmer Scientific Biological Sample Cryopreservation Product Portfolio
- 8.38.5 Helmer Scientific Recent Developments
- 8.39 Micronic
- 8.39.1 Micronic Company Information
- 8.39.2 Micronic Business Overview
- 8.39.3 Micronic Biological Sample Cryopreservation Revenue and Gross Margin (2021-2026)
- 8.39.4 Micronic Biological Sample Cryopreservation Product Portfolio
- 8.39.5 Micronic Recent Developments
- 8.40 OriGen Biomedical
- 8.40.1 OriGen Biomedical Company Information
- 8.40.2 OriGen Biomedical Business Overview
- 8.40.3 OriGen Biomedical Biological Sample Cryopreservation Revenue and Gross Margin (2021-2026)
- 8.40.4 OriGen Biomedical Biological Sample Cryopreservation Product Portfolio
- 8.40.5 OriGen Biomedical Recent Developments
- 8.41 BINDER
- 8.41.1 BINDER Company Information
- 8.41.2 BINDER Business Overview
- 8.41.3 BINDER Biological Sample Cryopreservation Revenue and Gross Margin (2021-2026)
- 8.41.4 BINDER Biological Sample Cryopreservation Product Portfolio
- 8.41.5 BINDER Recent Developments
- 8.42 Liebherr
- 8.42.1 Liebherr Company Information
- 8.42.2 Liebherr Business Overview
- 8.42.3 Liebherr Biological Sample Cryopreservation Revenue and Gross Margin (2021-2026)
- 8.42.4 Liebherr Biological Sample Cryopreservation Product Portfolio
- 8.42.5 Liebherr Recent Developments
- 8.43 Esco Lifesciences
- 8.43.1 Esco Lifesciences Company Information
- 8.43.2 Esco Lifesciences Business Overview
- 8.43.3 Esco Lifesciences Biological Sample Cryopreservation Revenue and Gross Margin (2021-2026)
- 8.43.4 Esco Lifesciences Biological Sample Cryopreservation Product Portfolio
- 8.43.5 Esco Lifesciences Recent Developments
- 8.44 Cryopal
- 8.44.1 Cryopal Company Information
- 8.44.2 Cryopal Business Overview
- 8.44.3 Cryopal Biological Sample Cryopreservation Revenue and Gross Margin (2021-2026)
- 8.44.4 Cryopal Biological Sample Cryopreservation Product Portfolio
- 8.44.5 Cryopal Recent Developments
- 8.45 Cryotherm
- 8.45.1 Cryotherm Company Information
- 8.45.2 Cryotherm Business Overview
- 8.45.3 Cryotherm Biological Sample Cryopreservation Revenue and Gross Margin (2021-2026)
- 8.45.4 Cryotherm Biological Sample Cryopreservation Product Portfolio
- 8.45.5 Cryotherm Recent Developments
- 8.46 Cryo Diffusion
- 8.46.1 Cryo Diffusion Company Information
- 8.46.2 Cryo Diffusion Business Overview
- 8.46.3 Cryo Diffusion Biological Sample Cryopreservation Revenue and Gross Margin (2021-2026)
- 8.46.4 Cryo Diffusion Biological Sample Cryopreservation Product Portfolio
- 8.46.5 Cryo Diffusion Recent Developments
- 8.47 Statebourne Cryogenics
- 8.47.1 Statebourne Cryogenics Company Information
- 8.47.2 Statebourne Cryogenics Business Overview
- 8.47.3 Statebourne Cryogenics Biological Sample Cryopreservation Revenue and Gross Margin (2021-2026)
- 8.47.4 Statebourne Cryogenics Biological Sample Cryopreservation Product Portfolio
- 8.47.5 Statebourne Cryogenics Recent Developments
- 8.48 Celltrio
- 8.48.1 Celltrio Company Information
- 8.48.2 Celltrio Business Overview
- 8.48.3 Celltrio Biological Sample Cryopreservation Revenue and Gross Margin (2021-2026)
- 8.48.4 Celltrio Biological Sample Cryopreservation Product Portfolio
- 8.48.5 Celltrio Recent Developments
- 8.49 ThermoGenesis
- 8.49.1 ThermoGenesis Company Information
- 8.49.2 ThermoGenesis Business Overview
- 8.49.3 ThermoGenesis Biological Sample Cryopreservation Revenue and Gross Margin (2021-2026)
- 8.49.4 ThermoGenesis Biological Sample Cryopreservation Product Portfolio
- 8.49.5 ThermoGenesis Recent Developments
- 8.50 Jiangsu SERLNG
- 8.50.1 Jiangsu SERLNG Company Information
- 8.50.2 Jiangsu SERLNG Business Overview
- 8.50.3 Jiangsu SERLNG Biological Sample Cryopreservation Revenue and Gross Margin (2021-2026)
- 8.50.4 Jiangsu SERLNG Biological Sample Cryopreservation Product Portfolio
- 8.50.5 Jiangsu SERLNG Recent Developments
- 8.51 SYLAB
- 8.51.1 SYLAB Company Information
- 8.51.2 SYLAB Business Overview
- 8.51.3 SYLAB Biological Sample Cryopreservation Revenue and Gross Margin (2021-2026)
- 8.51.4 SYLAB Biological Sample Cryopreservation Product Portfolio
- 8.51.5 SYLAB Recent Developments
- 8.52 Consarctic
- 8.52.1 Consarctic Company Information
- 8.52.2 Consarctic Business Overview
- 8.52.3 Consarctic Biological Sample Cryopreservation Revenue and Gross Margin (2021-2026)
- 8.52.4 Consarctic Biological Sample Cryopreservation Product Portfolio
- 8.52.5 Consarctic Recent Developments
- 8.53 PromoCell
- 8.53.1 PromoCell Company Information
- 8.53.2 PromoCell Business Overview
- 8.53.3 PromoCell Biological Sample Cryopreservation Revenue and Gross Margin (2021-2026)
- 8.53.4 PromoCell Biological Sample Cryopreservation Product Portfolio
- 8.53.5 PromoCell Recent Developments
- 8.54 FertiPro
- 8.54.1 FertiPro Company Information
- 8.54.2 FertiPro Business Overview
- 8.54.3 FertiPro Biological Sample Cryopreservation Revenue and Gross Margin (2021-2026)
- 8.54.4 FertiPro Biological Sample Cryopreservation Product Portfolio
- 8.54.5 FertiPro Recent Developments
- 8.55 CryoLogic
- 8.55.1 CryoLogic Company Information
- 8.55.2 CryoLogic Business Overview
- 8.55.3 CryoLogic Biological Sample Cryopreservation Revenue and Gross Margin (2021-2026)
- 8.55.4 CryoLogic Biological Sample Cryopreservation Product Portfolio
- 8.55.5 CryoLogic Recent Developments
- 8.56 Cryofab
- 8.56.1 Cryofab Company Information
- 8.56.2 Cryofab Business Overview
- 8.56.3 Cryofab Biological Sample Cryopreservation Revenue and Gross Margin (2021-2026)
- 8.56.4 Cryofab Biological Sample Cryopreservation Product Portfolio
- 8.56.5 Cryofab Recent Developments
9 Concluding Insights
10 Appendix
- 10.1 Reasons for Doing This Study
- 10.2 Research Methodology
- 10.3 Research Process
- 10.4 Authors List of This Report
- 10.5 Data Source
- 10.5.1 Secondary Sources
- 10.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst